,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,A,2021-08-24 11:50:54,2021-08-20,INVA,Zhen Marianne,Chief Accounting Officer,S - Sale,$15.89,-1129,35364,-3%,"-$17,940",,,,,INVA
1,M,2021-08-23 17:02:05,2021-08-19,INVA,Zhen Marianne,Chief Accounting Officer,S - Sale,$15.98,-3931,34604,-10%,"-$62,828",,,,,INVA
2,M,2021-05-25 18:44:42,2021-05-21,INVA,Bickerstaff George,Dir,P - Purchase,$13.21,20000,124560,+19%,"+$264,289",,,,,INVA
3,,2021-05-24 17:04:29,2021-05-20,INVA,Glaxosmithkline Plc,10%,S - Sale,$12.25,-32005260,0,-100%,"-$392,064,435",,,,,INVA
4,,2020-02-24 16:40:03,2020-02-24,INVA,Zhen Marianne,Chief Accounting Officer,S - Sale,$14.78,-2954,21913,-12%,"-$43,660",,,,,INVA
5,,2019-02-22 17:27:56,2019-02-21,INVA,Bickerstaff George,Dir,P - Purchase,$14.90,10000,38762,+35%,"+$148,958",,,,,INVA
6,,2019-02-20 16:02:31,2019-02-15,INVA,Hulme Geoffrey,Interim PEO,P - Purchase,$14.80,7000,19500,+56%,"+$103,600",,,,,INVA
7,,2018-08-22 18:46:58,2018-08-21,INVA,Abercrombie George B,"SVP, Chief Comm. Officer",S - Sale,$14.11,-8000,285479,-3%,"-$112,840",,,,,INVA
8,,2018-08-22 18:43:11,2018-08-21,INVA,Witek Theodore J. Jr.,"SVP, Chief Scientific Officer",S - Sale,$14.12,-8504,247767,-3%,"-$120,080",,,,,INVA
